Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
No of Months
12
12
12
12
Profit Before Tax
-154.00
-516.00
-659.00
-1,072.00
Adjustment
0.00
0.00
0.00
0.00
Changes In working Capital
-521.00
304.00
40.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-465.00
65.00
-318.00
-633.00
Cash Flow from Investing Activities
-891.00
-1,133.00
-37.00
-113.00
Cash Flow from Financing Activities
1,124.00
2,633.00
367.00
828.00
Net Cash Inflow / Outflow
-208.00
1,586.00
12.00
79.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
24.00
21.00
0.00
-1.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-154.550687629788
3967.38955463598
-4,121.00
-103.90%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-521.771881966813
-1048.55102552693
527.00
50.24%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-465.966880793112
3966.6550226362
-4,431.00
-111.75%
Cash Flow from Investing Activities
-891.237419657821
-6686.31376988822
5,795.00
86.67%
Cash Flow from Financing Activities
1124.57756969856
-1105.20158385073
2,229.00
201.75%
Net Cash Inflow / Outflow
-208.464802422162
-3817.12369843519
3,609.00
94.54%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
24.1619283302103
7.73663266754827
17.00
212.31%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -814.78% vs 120.48% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-465.97
65.19
-814.78%






